aluates Reports

$ 0.0

Automative

Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-25P15577

Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2023

BUY CHAPTERS

Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2025

Code: QYRE-Auto-25P15577

Report

May 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F. Hoffman-La Roche Ltd.

Thermo Fisher Scientific Inc

Agilent Technologies Inc

Illumina Inc

The Menarini Group

Bio-Rad Laboratories Inc

Qiagen NV

Exact Sciences Corporation

Bio Techne Corporation

Archerdx

NeoGenomics Laboratories Inc.

GUARDANT HEALTH, INC

Myriad Genetics Inc

Foundation Medicine, Inc

Amoy Diagnostics Co.,Ltd.

Biocartis Group Nv

Liquid Biopsy For Cancer Diagnostics Market Size

The global market for Liquid Biopsy For Cancer Diagnostics was valued at US$ 4348 million in the year 2024 and is projected to reach a revised size of US$ 9746 million by 2031, growing at a CAGR of 12.4% during the forecast period.

Liquid Biopsy For Cancer Diagnostics Market

Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.

Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.

This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy For Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy For Cancer Diagnostics.

The Liquid Biopsy For Cancer Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liquid Biopsy For Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liquid Biopsy For Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Liquid Biopsy For Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Liquid Biopsy For Cancer Diagnostics Market
Accounted market size in year	US$ 4348 million
Forecasted market size in 2031	US$ 9746 million
CAGR	12.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Blood Test Urine Test Saliva Test
Segment by Application	Hospital Diagnostic Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy For Cancer Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Liquid Biopsy For Cancer Diagnostics Market growing?

Ans: The Liquid Biopsy For Cancer Diagnostics Market witnessing a CAGR of 12.4% during the forecast period 2025-2031.

What is the Liquid Biopsy For Cancer Diagnostics Market size in 2031?

Ans: The Liquid Biopsy For Cancer Diagnostics Market size in 2031 will be US$ 9746 million.

Who are the main players in the Liquid Biopsy For Cancer Diagnostics Market report?

Ans: The main players in the Liquid Biopsy For Cancer Diagnostics Market are F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation, Bio-Techne Corporation, ArcherDX Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Myriad Genetics Inc., Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., Biocartis Group NV

What are the Application segmentation covered in the Liquid Biopsy For Cancer Diagnostics Market report?

Ans: The Applications covered in the Liquid Biopsy For Cancer Diagnostics Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the Liquid Biopsy For Cancer Diagnostics Market report?

Ans: The Types covered in the Liquid Biopsy For Cancer Diagnostics Market report are Blood Test, Urine Test, Saliva Test

Recommended Reports

Cancer Diagnostics

Liquid Biopsy

Molecular Tests

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Blood Test

1.2.3 Urine Test

1.2.4 Saliva Test

1.3 Market by Application

1.3.1 Global Liquid Biopsy For Cancer Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Liquid Biopsy For Cancer Diagnostics Market Perspective (2020-2031)

2.2 Global Liquid Biopsy For Cancer Diagnostics Growth Trends by Region

2.2.1 Global Liquid Biopsy For Cancer Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Liquid Biopsy For Cancer Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Liquid Biopsy For Cancer Diagnostics Market Dynamics

2.3.1 Liquid Biopsy For Cancer Diagnostics Industry Trends

2.3.2 Liquid Biopsy For Cancer Diagnostics Market Drivers

2.3.3 Liquid Biopsy For Cancer Diagnostics Market Challenges

2.3.4 Liquid Biopsy For Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Liquid Biopsy For Cancer Diagnostics Players by Revenue

3.1.1 Global Top Liquid Biopsy For Cancer Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Liquid Biopsy For Cancer Diagnostics Revenue

3.4 Global Liquid Biopsy For Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Liquid Biopsy For Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy For Cancer Diagnostics Revenue in 2024

3.5 Global Key Players of Liquid Biopsy For Cancer Diagnostics Head office and Area Served

3.6 Global Key Players of Liquid Biopsy For Cancer Diagnostics, Product and Application

3.7 Global Key Players of Liquid Biopsy For Cancer Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Liquid Biopsy For Cancer Diagnostics Breakdown Data by Type

4.1 Global Liquid Biopsy For Cancer Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Type (2026-2031)

5 Liquid Biopsy For Cancer Diagnostics Breakdown Data by Application

5.1 Global Liquid Biopsy For Cancer Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Liquid Biopsy For Cancer Diagnostics Market Size (2020-2031)

6.2 North America Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025)

6.4 North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Liquid Biopsy For Cancer Diagnostics Market Size (2020-2031)

7.2 Europe Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025)

7.4 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Liquid Biopsy For Cancer Diagnostics Market Size (2020-2031)

9.2 Latin America Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffman La Roche Ltd.

11.1.1 F. Hoffman La Roche Ltd. Company Details

11.1.2 F. Hoffman La Roche Ltd. Business Overview

11.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Introduction

11.1.4 F. Hoffman La Roche Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.1.5 F. Hoffman La Roche Ltd. Recent Development

11.2 Thermo Fisher Scientific Inc.

11.2.1 Thermo Fisher Scientific Inc. Company Details

11.2.2 Thermo Fisher Scientific Inc. Business Overview

11.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.2.4 Thermo Fisher Scientific Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.2.5 Thermo Fisher Scientific Inc. Recent Development

11.3 Agilent Technologies Inc.

11.3.1 Agilent Technologies Inc. Company Details

11.3.2 Agilent Technologies Inc. Business Overview

11.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.3.4 Agilent Technologies Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.3.5 Agilent Technologies Inc. Recent Development

11.4 Illumina Inc.

11.4.1 Illumina Inc. Company Details

11.4.2 Illumina Inc. Business Overview

11.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.4.4 Illumina Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.4.5 Illumina Inc. Recent Development

11.5 The Menarini Group

11.5.1 The Menarini Group Company Details

11.5.2 The Menarini Group Business Overview

11.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Introduction

11.5.4 The Menarini Group Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.5.5 The Menarini Group Recent Development

11.6 Bio-Rad Laboratories Inc.

11.6.1 Bio-Rad Laboratories Inc. Company Details

11.6.2 Bio-Rad Laboratories Inc. Business Overview

11.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.6.4 Bio-Rad Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.6.5 Bio-Rad Laboratories Inc. Recent Development

11.7 QIAGEN Inc.

11.7.1 QIAGEN Inc. Company Details

11.7.2 QIAGEN Inc. Business Overview

11.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.7.4 QIAGEN Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.7.5 QIAGEN Inc. Recent Development

11.8 Exact Sciences Corporation

11.8.1 Exact Sciences Corporation Company Details

11.8.2 Exact Sciences Corporation Business Overview

11.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Introduction

11.8.4 Exact Sciences Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.8.5 Exact Sciences Corporation Recent Development

11.9 Bio-Techne Corporation

11.9.1 Bio-Techne Corporation Company Details

11.9.2 Bio-Techne Corporation Business Overview

11.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Introduction

11.9.4 Bio-Techne Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.9.5 Bio-Techne Corporation Recent Development

11.10 ArcherDX Inc.

11.10.1 ArcherDX Inc. Company Details

11.10.2 ArcherDX Inc. Business Overview

11.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.10.4 ArcherDX Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.10.5 ArcherDX Inc. Recent Development

11.11 Neogenomics Laboratories Inc.

11.11.1 Neogenomics Laboratories Inc. Company Details

11.11.2 Neogenomics Laboratories Inc. Business Overview

11.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.11.4 Neogenomics Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.11.5 Neogenomics Laboratories Inc. Recent Development

11.12 Guardant Health Inc.

11.12.1 Guardant Health Inc. Company Details

11.12.2 Guardant Health Inc. Business Overview

11.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.12.4 Guardant Health Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.12.5 Guardant Health Inc. Recent Development

11.13 Myriad Genetics Inc.

11.13.1 Myriad Genetics Inc. Company Details

11.13.2 Myriad Genetics Inc. Business Overview

11.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.13.4 Myriad Genetics Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.13.5 Myriad Genetics Inc. Recent Development

11.14 Foundation Medicine Inc.

11.14.1 Foundation Medicine Inc. Company Details

11.14.2 Foundation Medicine Inc. Business Overview

11.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Introduction

11.14.4 Foundation Medicine Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.14.5 Foundation Medicine Inc. Recent Development

11.15 Amoy Diagnostics Co. Ltd.

11.15.1 Amoy Diagnostics Co. Ltd. Company Details

11.15.2 Amoy Diagnostics Co. Ltd. Business Overview

11.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Introduction

11.15.4 Amoy Diagnostics Co. Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.15.5 Amoy Diagnostics Co. Ltd. Recent Development

11.16 Biocartis Group NV

11.16.1 Biocartis Group NV Company Details

11.16.2 Biocartis Group NV Business Overview

11.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Introduction

11.16.4 Biocartis Group NV Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

11.16.5 Biocartis Group NV Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F. Hoffman-La Roche Ltd.

Thermo Fisher Scientific Inc

Agilent Technologies Inc

Illumina Inc

The Menarini Group

Bio-Rad Laboratories Inc

Qiagen NV

Exact Sciences Corporation

Bio Techne Corporation

Archerdx

NeoGenomics Laboratories Inc.

GUARDANT HEALTH, INC

Myriad Genetics Inc

Foundation Medicine, Inc

Amoy Diagnostics Co.,Ltd.

Biocartis Group Nv

List of Tables

Table 1. Global Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Blood Test

Table 3. Key Players of Urine Test

Table 4. Key Players of Saliva Test

Table 5. Global Liquid Biopsy For Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Liquid Biopsy For Cancer Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Liquid Biopsy For Cancer Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Liquid Biopsy For Cancer Diagnostics Market Share by Region (2020-2025)

Table 9. Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Liquid Biopsy For Cancer Diagnostics Market Share by Region (2026-2031)

Table 11. Liquid Biopsy For Cancer Diagnostics Market Trends

Table 12. Liquid Biopsy For Cancer Diagnostics Market Drivers

Table 13. Liquid Biopsy For Cancer Diagnostics Market Challenges

Table 14. Liquid Biopsy For Cancer Diagnostics Market Restraints

Table 15. Global Liquid Biopsy For Cancer Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Liquid Biopsy For Cancer Diagnostics Market Share by Players (2020-2025)

Table 17. Global Top Liquid Biopsy For Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy For Cancer Diagnostics as of 2024)

Table 18. Ranking of Global Top Liquid Biopsy For Cancer Diagnostics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Liquid Biopsy For Cancer Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Liquid Biopsy For Cancer Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Liquid Biopsy For Cancer Diagnostics, Product and Application

Table 22. Global Key Players of Liquid Biopsy For Cancer Diagnostics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Liquid Biopsy For Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Type (2020-2025)

Table 26. Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Type (2026-2031)

Table 28. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Application (2020-2025)

Table 30. Global Liquid Biopsy For Cancer Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Application (2026-2031)

Table 32. North America Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 47. F. Hoffman La Roche Ltd. Company Details

Table 48. F. Hoffman La Roche Ltd. Business Overview

Table 49. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product

Table 50. F. Hoffman La Roche Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 51. F. Hoffman La Roche Ltd. Recent Development

Table 52. Thermo Fisher Scientific Inc. Company Details

Table 53. Thermo Fisher Scientific Inc. Business Overview

Table 54. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 55. Thermo Fisher Scientific Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 56. Thermo Fisher Scientific Inc. Recent Development

Table 57. Agilent Technologies Inc. Company Details

Table 58. Agilent Technologies Inc. Business Overview

Table 59. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 60. Agilent Technologies Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 61. Agilent Technologies Inc. Recent Development

Table 62. Illumina Inc. Company Details

Table 63. Illumina Inc. Business Overview

Table 64. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 65. Illumina Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 66. Illumina Inc. Recent Development

Table 67. The Menarini Group Company Details

Table 68. The Menarini Group Business Overview

Table 69. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product

Table 70. The Menarini Group Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 71. The Menarini Group Recent Development

Table 72. Bio-Rad Laboratories Inc. Company Details

Table 73. Bio-Rad Laboratories Inc. Business Overview

Table 74. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 75. Bio-Rad Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Bio-Rad Laboratories Inc. Recent Development

Table 77. QIAGEN Inc. Company Details

Table 78. QIAGEN Inc. Business Overview

Table 79. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 80. QIAGEN Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 81. QIAGEN Inc. Recent Development

Table 82. Exact Sciences Corporation Company Details

Table 83. Exact Sciences Corporation Business Overview

Table 84. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product

Table 85. Exact Sciences Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 86. Exact Sciences Corporation Recent Development

Table 87. Bio-Techne Corporation Company Details

Table 88. Bio-Techne Corporation Business Overview

Table 89. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product

Table 90. Bio-Techne Corporation Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 91. Bio-Techne Corporation Recent Development

Table 92. ArcherDX Inc. Company Details

Table 93. ArcherDX Inc. Business Overview

Table 94. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 95. ArcherDX Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 96. ArcherDX Inc. Recent Development

Table 97. Neogenomics Laboratories Inc. Company Details

Table 98. Neogenomics Laboratories Inc. Business Overview

Table 99. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 100. Neogenomics Laboratories Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 101. Neogenomics Laboratories Inc. Recent Development

Table 102. Guardant Health Inc. Company Details

Table 103. Guardant Health Inc. Business Overview

Table 104. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 105. Guardant Health Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 106. Guardant Health Inc. Recent Development

Table 107. Myriad Genetics Inc. Company Details

Table 108. Myriad Genetics Inc. Business Overview

Table 109. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 110. Myriad Genetics Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 111. Myriad Genetics Inc. Recent Development

Table 112. Foundation Medicine Inc. Company Details

Table 113. Foundation Medicine Inc. Business Overview

Table 114. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product

Table 115. Foundation Medicine Inc. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 116. Foundation Medicine Inc. Recent Development

Table 117. Amoy Diagnostics Co. Ltd. Company Details

Table 118. Amoy Diagnostics Co. Ltd. Business Overview

Table 119. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product

Table 120. Amoy Diagnostics Co. Ltd. Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 121. Amoy Diagnostics Co. Ltd. Recent Development

Table 122. Biocartis Group NV Company Details

Table 123. Biocartis Group NV Business Overview

Table 124. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product

Table 125. Biocartis Group NV Revenue in Liquid Biopsy For Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 126. Biocartis Group NV Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

Table 130. Authors List of This Report

List of Figures

Figure 1. Liquid Biopsy For Cancer Diagnostics Picture

Figure 2. Global Liquid Biopsy For Cancer Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Liquid Biopsy For Cancer Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Blood Test Features

Figure 5. Urine Test Features

Figure 6. Saliva Test Features

Figure 7. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Liquid Biopsy For Cancer Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Diagnostic Center Case Studies

Figure 11. Others Case Studies

Figure 12. Liquid Biopsy For Cancer Diagnostics Report Years Considered

Figure 13. Global Liquid Biopsy For Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Liquid Biopsy For Cancer Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Liquid Biopsy For Cancer Diagnostics Market Share by Region: 2024 VS 2031

Figure 16. Global Liquid Biopsy For Cancer Diagnostics Market Share by Players in 2024

Figure 17. Global Top Liquid Biopsy For Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy For Cancer Diagnostics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Liquid Biopsy For Cancer Diagnostics Revenue in 2024

Figure 19. North America Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Liquid Biopsy For Cancer Diagnostics Market Share by Country (2020-2031)

Figure 21. United States Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Liquid Biopsy For Cancer Diagnostics Market Share by Country (2020-2031)

Figure 25. Germany Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Share by Region (2020-2031)

Figure 33. China Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Liquid Biopsy For Cancer Diagnostics Market Share by Country (2020-2031)

Figure 41. Mexico Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Share by Country (2020-2031)

Figure 45. Turkey Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Liquid Biopsy For Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. F. Hoffman La Roche Ltd. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 49. Thermo Fisher Scientific Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 50. Agilent Technologies Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 51. Illumina Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 52. The Menarini Group Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 53. Bio-Rad Laboratories Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 54. QIAGEN Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 55. Exact Sciences Corporation Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 56. Bio-Techne Corporation Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 57. ArcherDX Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 58. Neogenomics Laboratories Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 59. Guardant Health Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 60. Myriad Genetics Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 61. Foundation Medicine Inc. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 62. Amoy Diagnostics Co. Ltd. Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 63. Biocartis Group NV Revenue Growth Rate in Liquid Biopsy For Cancer Diagnostics Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Liquid Biopsy Diagnostic Tool Market Research Report 2025

Global Liquid Biopsy Services Market Research Report 2025

Global Canine Liquid Biopsy Market Research Report 2024

Global Canine Fluid Biopsy Market Research Report 2025

Global Canine Biopsy Services Market Research Report 2025

Global Canine Tumor Screening Market Research Report 2024

Global Tumor Liquid Biopsy Kit Market Research Report 2024

Global Canine Cancer Detection Market Research Report 2024

Global Liquid Biopsy IVD Market Size Status and Forecast 2021 2027

Global Circulating Tumor DNA Diagnostics Market Research Report 2025

Global Liquid Biopsy Test Kit Market Research Report 2024

Global Non Invasive Cancer Detection Market Research Report 2024

Global Multi Cancer Detection Blood Test Market Research Report 2024

Global Liquid Biopsy Products Market Insights Forecast to 2030

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Global Cell free Tumor DNA Detection Market Research Report 2025

Global Cancer Biopsy Market Size Status and Forecast 2021 2027

Global Noninvasive Cancer Diagnostics and Technology Market Research Report 2025

Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions